Hajime Sakai
Founder at Napigen, Inc.
Net worth: 688 123 $ as of 2024-05-30
Profile
Hajime Sakai has founded Napigen, Inc. in 2016 and currently holds the titles of President, Chief Executive Officer & Director.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SHINTO PAINT CO., LTD.
1.07% | 2023-09-29 | 332,000 ( 1.07% ) | 266 201 $ | 2024-05-30 |
TOWNNEWS-SHA CO., LTD.
0.89% | 2023-06-29 | 49,500 ( 0.89% ) | 242 547 $ | 2024-05-30 |
| 2023-12-30 | 243,000 ( 1.30% ) | 179 375 $ | 2024-05-30 |
Hajime Sakai active positions
| Companies | Position | Start |
|---|---|---|
Napigen, Inc.
 Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Founder | 2015-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Process Industries |
- Stock Market
- Insiders
- Hajime Sakai
